Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pdgfra-Associated Chronic Eosinophilic Leukemia × Immunologic Techniques × Clear all

Sponsor

Conditions

Uveal Melanoma 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Osteosarcoma 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Neoplasms, Neuroepithelial 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Melanoma 1 Medulloblastoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia 1 Graft vs Host Disease 1 Gliosarcoma 1 Glioma, Subependymal 1 Glioma 1 Glioblastoma 1 Familial ependymoma 1

Interventions

fludarabine phosphate 9 Whole-Body Irradiation 7 Peripheral Blood Stem Cell Transplantation 7 Cyclophosphamide 7 Busulfan 7 Mycophenolic Acid 6 Antilymphocyte Serum 6 Tacrolimus 5 Methotrexate 5 Cyclosporine 5 Melphalan 4 Etoposide 4 thymoglobulin 3 Sirolimus 3 Rituximab 3 Cord Blood Stem Cell Transplantation 3 Radiotherapy 2 Ondansetron 2 Granulocyte Colony-Stimulating Factor 2 Dexamethasone 2 Cytarabine 2 Cyclosporins 2 Carmustine 2 Calcium Dobesilate 2 Aprepitant 2 rasburicase 1 fludarabine 1 etoposide phosphate 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡